Dr. Dietmar Thurnher, MD
Claim this profileLKH - Universitätsklinikum Graz - HNO-Universitätsklinik
Studies Head and Neck Cancers
Studies Squamous Cell Carcinoma
2 reported clinical trials
4 drugs studied
Area of expertise
1Head And Neck Cancers
p16 negative
p16 positive
Stage II
2Squamous Cell Carcinoma
p16 positive
p16 negative
Clinical Trials Dietmar Thurnher, MD is currently running
More about Dietmar Thurnher, MD
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical TrialTreatments Dietmar Thurnher, MD has experience with
- IMRT
- Xevinapant (Debio 1143)
- Cetuximab
- NBTXR3
Breakdown of trials Dietmar Thurnher, MD has run
Head and Neck Cancers
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dietmar Thurnher, MD specialize in?
Dietmar Thurnher, MD focuses on Head and Neck Cancers and Squamous Cell Carcinoma. In particular, much of their work with Head and Neck Cancers has involved p16 negative patients, or patients who are p16 positive.
Is Dietmar Thurnher, MD currently recruiting for clinical trials?
Yes, Dietmar Thurnher, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Dietmar Thurnher, MD has studied deeply?
Yes, Dietmar Thurnher, MD has studied treatments such as IMRT, Xevinapant (Debio 1143), Cetuximab.
What is the best way to schedule an appointment with Dietmar Thurnher, MD?
Apply for one of the trials that Dietmar Thurnher, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.